NM_174936.4:c.1503+50_1503+71delGTGTGTGTGTGTGTGTGTGTGT

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong

The NM_174936.4(PCSK9):​c.1503+50_1503+71delGTGTGTGTGTGTGTGTGTGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00060 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00085 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PCSK9
NM_174936.4 intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.564

Publications

1 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP6
Variant 1-55058666-CGTGTGTGTGTGTGTGTGTGTGT-C is Benign according to our data. Variant chr1-55058666-CGTGTGTGTGTGTGTGTGTGTGT-C is described in ClinVar as Likely_benign. ClinVar VariationId is 492233.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCSK9NM_174936.4 linkc.1503+50_1503+71delGTGTGTGTGTGTGTGTGTGTGT intron_variant Intron 9 of 11 ENST00000302118.5 NP_777596.2 Q8NBP7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCSK9ENST00000302118.5 linkc.1503+20_1503+41delGTGTGTGTGTGTGTGTGTGTGT intron_variant Intron 9 of 11 1 NM_174936.4 ENSP00000303208.5 Q8NBP7-1

Frequencies

GnomAD3 genomes
AF:
0.000597
AC:
85
AN:
142440
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.000159
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000328
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00113
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000850
AC:
1184
AN:
1392822
Hom.:
0
AF XY:
0.000798
AC XY:
551
AN XY:
690614
show subpopulations
African (AFR)
AF:
0.000380
AC:
12
AN:
31608
American (AMR)
AF:
0.0000758
AC:
3
AN:
39552
Ashkenazi Jewish (ASJ)
AF:
0.000121
AC:
3
AN:
24878
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36984
South Asian (SAS)
AF:
0.0000738
AC:
6
AN:
81354
European-Finnish (FIN)
AF:
0.000250
AC:
12
AN:
47984
Middle Eastern (MID)
AF:
0.000249
AC:
1
AN:
4014
European-Non Finnish (NFE)
AF:
0.00104
AC:
1114
AN:
1068890
Other (OTH)
AF:
0.000573
AC:
33
AN:
57558
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
50
100
149
199
249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000597
AC:
85
AN:
142440
Hom.:
0
Cov.:
0
AF XY:
0.000566
AC XY:
39
AN XY:
68950
show subpopulations
African (AFR)
AF:
0.000159
AC:
6
AN:
37766
American (AMR)
AF:
0.000137
AC:
2
AN:
14588
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3364
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4752
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4378
European-Finnish (FIN)
AF:
0.000328
AC:
3
AN:
9152
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
296
European-Non Finnish (NFE)
AF:
0.00113
AC:
74
AN:
65320
Other (OTH)
AF:
0.00
AC:
0
AN:
1944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
1122

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypercholesterolemia, autosomal dominant, 3 Benign:1
Dec 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypercholesterolemia, familial, 1 Benign:1
Sep 05, 2017
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.56
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35115360; hg19: chr1-55524339; API